← Back to Clinical Trials
Recruiting NCT06924164

NCT06924164 Progressive Resistance Training for Adults With External Snapping Hip

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06924164
Status Recruiting
Phase
Sponsor Aarhus University Hospital
Condition External Snapping Hip
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2025-07-01
Primary Completion 2027-04-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Progressive resistance trainingWaiting timeSelf guided exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2025-07-01 with a primary completion date of 2027-04-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

External snapping hip is characterised by an audible and painful snap during hip movement among physical active people around 15-40 years old. Progressive resistance training has been suggested as a new potential treatment path in treating patients with external snapping hip. The investigators conducted a feasibility study and found that patients reported less pain and improved their physical function, quality of life and muscle strength after 12 weeks of progressive resistance training. The overall aim of the project is to compare hip pain in patients with external snapping hip treated with progressive resistance training to a wait-and-see approach, in a randomised controlled trial. This study has the potential to establish a new and specific treatment option for patients with external snapping hip, to be used nationally and internationally.

Eligibility Criteria

Inclusion criteria: * Age 18-40 years (10) * Experienced lateral hip joint "snapping" with pain discomfort within the last 14 days * Able to demonstrate the audible and/or visible lateral "snapping" during lateral hip joint movementor popping sound when the hip joint moves * Capable of commuting to the training facility * Proficient in reading and understanding Danish or English Exclusion criteria: * Previous surgery on the affected hip * Planned surgery on lower extremities within the trial period * Anterior or medial hip discomfort that substantially exceeds the lateral hip discomfort * Any contraindication to exercise * Neurological, rheumatoid, or mental conditions affecting the hip function * Ongoing active cancer treatment * Planned vacation for more than 14 days within the intervention period * Pregnancy

Contact & Investigator

Central Contact

Lisa U Tønning, MHSc

✉ lisatoenning@clin.au.dk

📞 +4526474080

Principal Investigator

Stig S Jakobsen, PhD

STUDY DIRECTOR

Department of Orthopedic Surgery, Aarhus University Hospital, DK

Frequently Asked Questions

Who can join the NCT06924164 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying External Snapping Hip. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06924164 currently recruiting?

Yes, NCT06924164 is actively recruiting participants. Contact the research team at lisatoenning@clin.au.dk for enrollment information.

Where is the NCT06924164 trial being conducted?

This trial is being conducted at Aalborg, Denmark, Aarhus N, Denmark, Copenhagen, Denmark, Copenhagen, Denmark and 9 additional locations.

Who is sponsoring the NCT06924164 clinical trial?

NCT06924164 is sponsored by Aarhus University Hospital. The principal investigator is Stig S Jakobsen, PhD at Department of Orthopedic Surgery, Aarhus University Hospital, DK. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology